nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—AHR—pancreatic cancer	0.673	1	CbGaD
Nimodipine—CYP3A5—Tamoxifen—pancreatic cancer	0.0273	0.186	CbGbCtD
Nimodipine—CYP3A5—Erlotinib—pancreatic cancer	0.0232	0.159	CbGbCtD
Nimodipine—CYP3A5—Irinotecan—pancreatic cancer	0.0209	0.143	CbGbCtD
Nimodipine—CYP3A5—Docetaxel—pancreatic cancer	0.0153	0.105	CbGbCtD
Nimodipine—CYP3A5—Sunitinib—pancreatic cancer	0.0153	0.104	CbGbCtD
Nimodipine—CYP3A4—Tamoxifen—pancreatic cancer	0.0106	0.0727	CbGbCtD
Nimodipine—CYP3A4—Erlotinib—pancreatic cancer	0.00904	0.0618	CbGbCtD
Nimodipine—CYP3A4—Irinotecan—pancreatic cancer	0.00817	0.0558	CbGbCtD
Nimodipine—CYP3A4—Docetaxel—pancreatic cancer	0.00598	0.0409	CbGbCtD
Nimodipine—CYP3A4—Sunitinib—pancreatic cancer	0.00596	0.0407	CbGbCtD
Nimodipine—CYP3A4—Doxorubicin—pancreatic cancer	0.00446	0.0305	CbGbCtD
Nimodipine—Ileus—Epirubicin—pancreatic cancer	0.000545	0.00483	CcSEcCtD
Nimodipine—Fluid retention—Docetaxel—pancreatic cancer	0.000543	0.00481	CcSEcCtD
Nimodipine—Cramp muscle—Irinotecan—pancreatic cancer	0.000541	0.00479	CcSEcCtD
Nimodipine—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.000541	0.00478	CcSEcCtD
Nimodipine—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.000532	0.00471	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Gemcitabine—pancreatic cancer	0.000516	0.00457	CcSEcCtD
Nimodipine—Bradycardia—Sunitinib—pancreatic cancer	0.000514	0.00455	CcSEcCtD
Nimodipine—Lightheadedness—Docetaxel—pancreatic cancer	0.000512	0.00453	CcSEcCtD
Nimodipine—Sweating increased—Irinotecan—pancreatic cancer	0.000506	0.00448	CcSEcCtD
Nimodipine—Hepatitis—Sunitinib—pancreatic cancer	0.000505	0.00447	CcSEcCtD
Nimodipine—Ileus—Doxorubicin—pancreatic cancer	0.000505	0.00447	CcSEcCtD
Nimodipine—Muscle spasms—Tamoxifen—pancreatic cancer	0.000493	0.00437	CcSEcCtD
Nimodipine—Phlebitis—Docetaxel—pancreatic cancer	0.000482	0.00427	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Docetaxel—pancreatic cancer	0.000478	0.00423	CcSEcCtD
Nimodipine—Anaemia—Tamoxifen—pancreatic cancer	0.000474	0.0042	CcSEcCtD
Nimodipine—Flushing—Sunitinib—pancreatic cancer	0.000468	0.00415	CcSEcCtD
Nimodipine—Cardiac disorder—Sunitinib—pancreatic cancer	0.000468	0.00415	CcSEcCtD
Nimodipine—Cardiac failure congestive—Docetaxel—pancreatic cancer	0.000458	0.00406	CcSEcCtD
Nimodipine—Angiopathy—Sunitinib—pancreatic cancer	0.000458	0.00405	CcSEcCtD
Nimodipine—Immune system disorder—Sunitinib—pancreatic cancer	0.000456	0.00404	CcSEcCtD
Nimodipine—Jaundice—Irinotecan—pancreatic cancer	0.000451	0.004	CcSEcCtD
Nimodipine—Hypertension—Tamoxifen—pancreatic cancer	0.000443	0.00392	CcSEcCtD
Nimodipine—Myalgia—Tamoxifen—pancreatic cancer	0.000437	0.00387	CcSEcCtD
Nimodipine—Myalgia—Erlotinib—pancreatic cancer	0.000432	0.00383	CcSEcCtD
Nimodipine—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000427	0.00378	CcSEcCtD
Nimodipine—Bradycardia—Irinotecan—pancreatic cancer	0.000423	0.00375	CcSEcCtD
Nimodipine—Muscle spasms—Sunitinib—pancreatic cancer	0.000422	0.00374	CcSEcCtD
Nimodipine—Oedema—Tamoxifen—pancreatic cancer	0.000419	0.00371	CcSEcCtD
Nimodipine—Hyponatraemia—Docetaxel—pancreatic cancer	0.000417	0.00369	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000415	0.00368	CcSEcCtD
Nimodipine—Oedema—Erlotinib—pancreatic cancer	0.000414	0.00367	CcSEcCtD
Nimodipine—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00041	0.00363	CcSEcCtD
Nimodipine—Nervous system disorder—Erlotinib—pancreatic cancer	0.000406	0.0036	CcSEcCtD
Nimodipine—Anaemia—Sunitinib—pancreatic cancer	0.000406	0.00359	CcSEcCtD
Nimodipine—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000406	0.00359	CcSEcCtD
Nimodipine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000405	0.00358	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Epirubicin—pancreatic cancer	0.000386	0.00342	CcSEcCtD
Nimodipine—Cardiac disorder—Irinotecan—pancreatic cancer	0.000386	0.00342	CcSEcCtD
Nimodipine—Flushing—Irinotecan—pancreatic cancer	0.000386	0.00342	CcSEcCtD
Nimodipine—Liver function test abnormal—Docetaxel—pancreatic cancer	0.000384	0.0034	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000381	0.00338	CcSEcCtD
Nimodipine—Hypertension—Sunitinib—pancreatic cancer	0.000379	0.00336	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000377	0.00334	CcSEcCtD
Nimodipine—Angiopathy—Irinotecan—pancreatic cancer	0.000377	0.00334	CcSEcCtD
Nimodipine—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000376	0.00333	CcSEcCtD
Nimodipine—Immune system disorder—Irinotecan—pancreatic cancer	0.000376	0.00332	CcSEcCtD
Nimodipine—Cramp muscle—Docetaxel—pancreatic cancer	0.000374	0.00331	CcSEcCtD
Nimodipine—Myalgia—Sunitinib—pancreatic cancer	0.000374	0.00331	CcSEcCtD
Nimodipine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000373	0.0033	CcSEcCtD
Nimodipine—Dyspnoea—Erlotinib—pancreatic cancer	0.000369	0.00327	CcSEcCtD
Nimodipine—Angiopathy—Gemcitabine—pancreatic cancer	0.000367	0.00325	CcSEcCtD
Nimodipine—Fluid retention—Epirubicin—pancreatic cancer	0.000367	0.00324	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000366	0.00324	CcSEcCtD
Nimodipine—Immune system disorder—Gemcitabine—pancreatic cancer	0.000366	0.00324	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000361	0.0032	CcSEcCtD
Nimodipine—Oedema—Sunitinib—pancreatic cancer	0.000359	0.00317	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000358	0.00317	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Doxorubicin—pancreatic cancer	0.000357	0.00316	CcSEcCtD
Nimodipine—Nervous system disorder—Sunitinib—pancreatic cancer	0.000352	0.00311	CcSEcCtD
Nimodipine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000351	0.00311	CcSEcCtD
Nimodipine—Muscle spasms—Irinotecan—pancreatic cancer	0.000348	0.00308	CcSEcCtD
Nimodipine—Fluid retention—Doxorubicin—pancreatic cancer	0.000339	0.003	CcSEcCtD
Nimodipine—Anaemia—Irinotecan—pancreatic cancer	0.000335	0.00296	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000327	0.00289	CcSEcCtD
Nimodipine—Anaemia—Gemcitabine—pancreatic cancer	0.000326	0.00288	CcSEcCtD
Nimodipine—Phlebitis—Epirubicin—pancreatic cancer	0.000325	0.00288	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.000322	0.00285	CcSEcCtD
Nimodipine—Anaemia—Fluorouracil—pancreatic cancer	0.00032	0.00284	CcSEcCtD
Nimodipine—Dyspnoea—Sunitinib—pancreatic cancer	0.00032	0.00283	CcSEcCtD
Nimodipine—Hypertension—Irinotecan—pancreatic cancer	0.000312	0.00277	CcSEcCtD
Nimodipine—Jaundice—Docetaxel—pancreatic cancer	0.000312	0.00276	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00031	0.00274	CcSEcCtD
Nimodipine—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000309	0.00274	CcSEcCtD
Nimodipine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000308	0.00273	CcSEcCtD
Nimodipine—Hypertension—Gemcitabine—pancreatic cancer	0.000304	0.00269	CcSEcCtD
Nimodipine—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000303	0.00268	CcSEcCtD
Nimodipine—Phlebitis—Doxorubicin—pancreatic cancer	0.000301	0.00266	CcSEcCtD
Nimodipine—Myalgia—Gemcitabine—pancreatic cancer	0.0003	0.00266	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.000298	0.00264	CcSEcCtD
Nimodipine—Pruritus—Tamoxifen—pancreatic cancer	0.000296	0.00262	CcSEcCtD
Nimodipine—Oedema—Irinotecan—pancreatic cancer	0.000295	0.00261	CcSEcCtD
Nimodipine—Myalgia—Fluorouracil—pancreatic cancer	0.000295	0.00261	CcSEcCtD
Nimodipine—Pruritus—Erlotinib—pancreatic cancer	0.000293	0.00259	CcSEcCtD
Nimodipine—Nervous system disorder—Irinotecan—pancreatic cancer	0.00029	0.00256	CcSEcCtD
Nimodipine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000289	0.00256	CcSEcCtD
Nimodipine—Oedema—Gemcitabine—pancreatic cancer	0.000288	0.00255	CcSEcCtD
Nimodipine—Hepatitis—Docetaxel—pancreatic cancer	0.000287	0.00254	CcSEcCtD
Nimodipine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000286	0.00254	CcSEcCtD
Nimodipine—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000286	0.00253	CcSEcCtD
Nimodipine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000286	0.00253	CcSEcCtD
Nimodipine—Diarrhoea—Erlotinib—pancreatic cancer	0.000283	0.00251	CcSEcCtD
Nimodipine—Oedema—Fluorouracil—pancreatic cancer	0.000283	0.0025	CcSEcCtD
Nimodipine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000282	0.0025	CcSEcCtD
Nimodipine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000282	0.00249	CcSEcCtD
Nimodipine—Hyponatraemia—Epirubicin—pancreatic cancer	0.000281	0.00249	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.00028	0.00248	CcSEcCtD
Nimodipine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000278	0.00246	CcSEcCtD
Nimodipine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000277	0.00246	CcSEcCtD
Nimodipine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000277	0.00245	CcSEcCtD
Nimodipine—Dizziness—Tamoxifen—pancreatic cancer	0.000277	0.00245	CcSEcCtD
Nimodipine—Tachycardia—Fluorouracil—pancreatic cancer	0.000276	0.00244	CcSEcCtD
Nimodipine—Hypotension—Irinotecan—pancreatic cancer	0.000276	0.00244	CcSEcCtD
Nimodipine—Dizziness—Erlotinib—pancreatic cancer	0.000274	0.00242	CcSEcCtD
Nimodipine—Hypotension—Gemcitabine—pancreatic cancer	0.000269	0.00238	CcSEcCtD
Nimodipine—Flushing—Docetaxel—pancreatic cancer	0.000267	0.00236	CcSEcCtD
Nimodipine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000267	0.00236	CcSEcCtD
Nimodipine—Vomiting—Tamoxifen—pancreatic cancer	0.000266	0.00236	CcSEcCtD
Nimodipine—Hypotension—Fluorouracil—pancreatic cancer	0.000264	0.00234	CcSEcCtD
Nimodipine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000264	0.00234	CcSEcCtD
Nimodipine—Rash—Tamoxifen—pancreatic cancer	0.000264	0.00234	CcSEcCtD
Nimodipine—Dermatitis—Tamoxifen—pancreatic cancer	0.000264	0.00233	CcSEcCtD
Nimodipine—Vomiting—Erlotinib—pancreatic cancer	0.000263	0.00233	CcSEcCtD
Nimodipine—Dyspnoea—Irinotecan—pancreatic cancer	0.000263	0.00233	CcSEcCtD
Nimodipine—Headache—Tamoxifen—pancreatic cancer	0.000262	0.00232	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000262	0.00232	CcSEcCtD
Nimodipine—Rash—Erlotinib—pancreatic cancer	0.000261	0.00231	CcSEcCtD
Nimodipine—Dermatitis—Erlotinib—pancreatic cancer	0.000261	0.00231	CcSEcCtD
Nimodipine—Angiopathy—Docetaxel—pancreatic cancer	0.000261	0.00231	CcSEcCtD
Nimodipine—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00026	0.0023	CcSEcCtD
Nimodipine—Immune system disorder—Docetaxel—pancreatic cancer	0.00026	0.0023	CcSEcCtD
Nimodipine—Headache—Erlotinib—pancreatic cancer	0.00026	0.0023	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000259	0.0023	CcSEcCtD
Nimodipine—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000259	0.00229	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000258	0.00228	CcSEcCtD
Nimodipine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000257	0.00227	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000255	0.00226	CcSEcCtD
Nimodipine—Pruritus—Sunitinib—pancreatic cancer	0.000254	0.00225	CcSEcCtD
Nimodipine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000252	0.00223	CcSEcCtD
Nimodipine—Nausea—Tamoxifen—pancreatic cancer	0.000249	0.0022	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000248	0.0022	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000247	0.00219	CcSEcCtD
Nimodipine—Nausea—Erlotinib—pancreatic cancer	0.000246	0.00218	CcSEcCtD
Nimodipine—Diarrhoea—Sunitinib—pancreatic cancer	0.000245	0.00217	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000244	0.00216	CcSEcCtD
Nimodipine—Muscle spasms—Docetaxel—pancreatic cancer	0.000241	0.00213	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000239	0.00212	CcSEcCtD
Nimodipine—Dizziness—Sunitinib—pancreatic cancer	0.000237	0.0021	CcSEcCtD
Nimodipine—Anaemia—Docetaxel—pancreatic cancer	0.000231	0.00205	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000229	0.00202	CcSEcCtD
Nimodipine—Vomiting—Sunitinib—pancreatic cancer	0.000228	0.00202	CcSEcCtD
Nimodipine—Rash—Sunitinib—pancreatic cancer	0.000226	0.002	CcSEcCtD
Nimodipine—Dermatitis—Sunitinib—pancreatic cancer	0.000226	0.002	CcSEcCtD
Nimodipine—Headache—Sunitinib—pancreatic cancer	0.000225	0.00199	CcSEcCtD
Nimodipine—Palpitations—Docetaxel—pancreatic cancer	0.000221	0.00196	CcSEcCtD
Nimodipine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000218	0.00193	CcSEcCtD
Nimodipine—Hypertension—Docetaxel—pancreatic cancer	0.000216	0.00191	CcSEcCtD
Nimodipine—Myalgia—Docetaxel—pancreatic cancer	0.000213	0.00189	CcSEcCtD
Nimodipine—Nausea—Sunitinib—pancreatic cancer	0.000213	0.00189	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—pancreatic cancer	0.000211	0.00186	CcSEcCtD
Nimodipine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000208	0.00185	CcSEcCtD
Nimodipine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000204	0.00181	CcSEcCtD
Nimodipine—Oedema—Docetaxel—pancreatic cancer	0.000204	0.00181	CcSEcCtD
Nimodipine—Pruritus—Gemcitabine—pancreatic cancer	0.000204	0.0018	CcSEcCtD
Nimodipine—Diarrhoea—Irinotecan—pancreatic cancer	0.000202	0.00179	CcSEcCtD
Nimodipine—Nervous system disorder—Docetaxel—pancreatic cancer	0.0002	0.00177	CcSEcCtD
Nimodipine—Pruritus—Fluorouracil—pancreatic cancer	0.0002	0.00177	CcSEcCtD
Nimodipine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.0002	0.00177	CcSEcCtD
Nimodipine—Tachycardia—Docetaxel—pancreatic cancer	0.000199	0.00176	CcSEcCtD
Nimodipine—Bradycardia—Epirubicin—pancreatic cancer	0.000197	0.00175	CcSEcCtD
Nimodipine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000197	0.00174	CcSEcCtD
Nimodipine—Dizziness—Irinotecan—pancreatic cancer	0.000195	0.00173	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—pancreatic cancer	0.000195	0.00172	CcSEcCtD
Nimodipine—Hepatitis—Epirubicin—pancreatic cancer	0.000194	0.00172	CcSEcCtD
Nimodipine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000194	0.00171	CcSEcCtD
Nimodipine—Hypotension—Docetaxel—pancreatic cancer	0.000191	0.00169	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000189	0.00167	CcSEcCtD
Nimodipine—Vomiting—Irinotecan—pancreatic cancer	0.000188	0.00166	CcSEcCtD
Nimodipine—Dizziness—Fluorouracil—pancreatic cancer	0.000187	0.00166	CcSEcCtD
Nimodipine—Rash—Irinotecan—pancreatic cancer	0.000186	0.00165	CcSEcCtD
Nimodipine—Dermatitis—Irinotecan—pancreatic cancer	0.000186	0.00165	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000186	0.00165	CcSEcCtD
Nimodipine—Headache—Irinotecan—pancreatic cancer	0.000185	0.00164	CcSEcCtD
Nimodipine—Vomiting—Gemcitabine—pancreatic cancer	0.000183	0.00162	CcSEcCtD
Nimodipine—Bradycardia—Doxorubicin—pancreatic cancer	0.000183	0.00162	CcSEcCtD
Nimodipine—Dyspnoea—Docetaxel—pancreatic cancer	0.000182	0.00161	CcSEcCtD
Nimodipine—Rash—Gemcitabine—pancreatic cancer	0.000181	0.00161	CcSEcCtD
Nimodipine—Dermatitis—Gemcitabine—pancreatic cancer	0.000181	0.0016	CcSEcCtD
Nimodipine—Headache—Gemcitabine—pancreatic cancer	0.00018	0.0016	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—pancreatic cancer	0.00018	0.00159	CcSEcCtD
Nimodipine—Flushing—Epirubicin—pancreatic cancer	0.00018	0.00159	CcSEcCtD
Nimodipine—Vomiting—Fluorouracil—pancreatic cancer	0.00018	0.00159	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—pancreatic cancer	0.000179	0.00159	CcSEcCtD
Nimodipine—Rash—Fluorouracil—pancreatic cancer	0.000178	0.00158	CcSEcCtD
Nimodipine—Dermatitis—Fluorouracil—pancreatic cancer	0.000178	0.00158	CcSEcCtD
Nimodipine—Headache—Fluorouracil—pancreatic cancer	0.000177	0.00157	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000176	0.00156	CcSEcCtD
Nimodipine—Angiopathy—Epirubicin—pancreatic cancer	0.000176	0.00156	CcSEcCtD
Nimodipine—Nausea—Irinotecan—pancreatic cancer	0.000175	0.00155	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—pancreatic cancer	0.000175	0.00155	CcSEcCtD
Nimodipine—Nausea—Gemcitabine—pancreatic cancer	0.000171	0.00151	CcSEcCtD
Nimodipine—Nausea—Fluorouracil—pancreatic cancer	0.000168	0.00149	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000166	0.00147	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—pancreatic cancer	0.000166	0.00147	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—pancreatic cancer	0.000163	0.00144	CcSEcCtD
Nimodipine—Muscle spasms—Epirubicin—pancreatic cancer	0.000162	0.00144	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000162	0.00143	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—pancreatic cancer	0.000156	0.00138	CcSEcCtD
Nimodipine—Hypersensitivity—Docetaxel—pancreatic cancer	0.00015	0.00133	CcSEcCtD
Nimodipine—Muscle spasms—Doxorubicin—pancreatic cancer	0.00015	0.00133	CcSEcCtD
Nimodipine—Palpitations—Epirubicin—pancreatic cancer	0.000149	0.00132	CcSEcCtD
Nimodipine—Hypertension—Epirubicin—pancreatic cancer	0.000146	0.00129	CcSEcCtD
Nimodipine—Pruritus—Docetaxel—pancreatic cancer	0.000144	0.00128	CcSEcCtD
Nimodipine—Anaemia—Doxorubicin—pancreatic cancer	0.000144	0.00128	CcSEcCtD
Nimodipine—Myalgia—Epirubicin—pancreatic cancer	0.000144	0.00127	CcSEcCtD
Nimodipine—Diarrhoea—Docetaxel—pancreatic cancer	0.00014	0.00124	CcSEcCtD
Nimodipine—Palpitations—Doxorubicin—pancreatic cancer	0.000138	0.00122	CcSEcCtD
Nimodipine—Oedema—Epirubicin—pancreatic cancer	0.000138	0.00122	CcSEcCtD
Nimodipine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000135	0.0012	CcSEcCtD
Nimodipine—Dizziness—Docetaxel—pancreatic cancer	0.000135	0.0012	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000135	0.00119	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—pancreatic cancer	0.000135	0.00119	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—pancreatic cancer	0.000134	0.00119	CcSEcCtD
Nimodipine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000133	0.00118	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—pancreatic cancer	0.000133	0.00118	CcSEcCtD
Nimodipine—Vomiting—Docetaxel—pancreatic cancer	0.00013	0.00115	CcSEcCtD
Nimodipine—Rash—Docetaxel—pancreatic cancer	0.000129	0.00114	CcSEcCtD
Nimodipine—Hypotension—Epirubicin—pancreatic cancer	0.000129	0.00114	CcSEcCtD
Nimodipine—Dermatitis—Docetaxel—pancreatic cancer	0.000129	0.00114	CcSEcCtD
Nimodipine—Headache—Docetaxel—pancreatic cancer	0.000128	0.00113	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—pancreatic cancer	0.000127	0.00113	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000125	0.00111	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000125	0.00111	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000125	0.0011	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—pancreatic cancer	0.000124	0.0011	CcSEcCtD
Nimodipine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000123	0.00109	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—pancreatic cancer	0.000123	0.00109	CcSEcCtD
Nimodipine—Nausea—Docetaxel—pancreatic cancer	0.000121	0.00107	CcSEcCtD
Nimodipine—Hypotension—Doxorubicin—pancreatic cancer	0.000119	0.00105	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000119	0.00105	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000116	0.00103	CcSEcCtD
Nimodipine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000114	0.00101	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00011	0.000974	CcSEcCtD
Nimodipine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000101	0.000898	CcSEcCtD
Nimodipine—Pruritus—Epirubicin—pancreatic cancer	9.74e-05	0.000863	CcSEcCtD
Nimodipine—Diarrhoea—Epirubicin—pancreatic cancer	9.42e-05	0.000834	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—pancreatic cancer	9.39e-05	0.000831	CcSEcCtD
Nimodipine—Dizziness—Epirubicin—pancreatic cancer	9.11e-05	0.000806	CcSEcCtD
Nimodipine—Pruritus—Doxorubicin—pancreatic cancer	9.02e-05	0.000798	CcSEcCtD
Nimodipine—Vomiting—Epirubicin—pancreatic cancer	8.76e-05	0.000775	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—pancreatic cancer	8.72e-05	0.000772	CcSEcCtD
Nimodipine—Rash—Epirubicin—pancreatic cancer	8.68e-05	0.000769	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—pancreatic cancer	8.68e-05	0.000768	CcSEcCtD
Nimodipine—Headache—Epirubicin—pancreatic cancer	8.63e-05	0.000764	CcSEcCtD
Nimodipine—Dizziness—Doxorubicin—pancreatic cancer	8.43e-05	0.000746	CcSEcCtD
Nimodipine—Nausea—Epirubicin—pancreatic cancer	8.18e-05	0.000724	CcSEcCtD
Nimodipine—Vomiting—Doxorubicin—pancreatic cancer	8.1e-05	0.000717	CcSEcCtD
Nimodipine—Rash—Doxorubicin—pancreatic cancer	8.04e-05	0.000711	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—pancreatic cancer	8.03e-05	0.000711	CcSEcCtD
Nimodipine—Headache—Doxorubicin—pancreatic cancer	7.98e-05	0.000707	CcSEcCtD
Nimodipine—Nausea—Doxorubicin—pancreatic cancer	7.57e-05	0.00067	CcSEcCtD
Nimodipine—CACNB3—Axon guidance—EGFR—pancreatic cancer	5.55e-05	0.000815	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—pancreatic cancer	5.51e-05	0.000808	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—STAT3—pancreatic cancer	5.45e-05	0.0008	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—NRAS—pancreatic cancer	5.44e-05	0.000798	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—EGFR—pancreatic cancer	5.4e-05	0.000792	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TYMP—pancreatic cancer	5.39e-05	0.000791	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NOTCH1—pancreatic cancer	5.36e-05	0.000787	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP2—pancreatic cancer	5.29e-05	0.000776	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—KRAS—pancreatic cancer	5.24e-05	0.00077	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SMAD4—pancreatic cancer	5.19e-05	0.000762	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CD44—pancreatic cancer	5.14e-05	0.000755	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ARG2—pancreatic cancer	5.13e-05	0.000753	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TYMP—pancreatic cancer	5.11e-05	0.000749	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—KRAS—pancreatic cancer	5.1e-05	0.000749	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HES1—pancreatic cancer	5.07e-05	0.000744	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PPARG—pancreatic cancer	5.06e-05	0.000743	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TGFB1—pancreatic cancer	5.05e-05	0.000742	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—HRAS—pancreatic cancer	5.02e-05	0.000737	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CTNNB1—pancreatic cancer	5e-05	0.000734	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—pancreatic cancer	4.95e-05	0.000727	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GCG—pancreatic cancer	4.93e-05	0.000724	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MMP9—pancreatic cancer	4.9e-05	0.000719	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MMP9—pancreatic cancer	4.89e-05	0.000718	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—HRAS—pancreatic cancer	4.89e-05	0.000717	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KDR—pancreatic cancer	4.88e-05	0.000716	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CTNNB1—pancreatic cancer	4.86e-05	0.000714	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MET—pancreatic cancer	4.78e-05	0.000701	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MMP9—pancreatic cancer	4.77e-05	0.0007	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—pancreatic cancer	4.72e-05	0.000692	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SMAD4—pancreatic cancer	4.69e-05	0.000688	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—KRAS—pancreatic cancer	4.68e-05	0.000687	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP2—pancreatic cancer	4.65e-05	0.000682	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP2—pancreatic cancer	4.65e-05	0.000682	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—STK11—pancreatic cancer	4.64e-05	0.00068	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KDR—pancreatic cancer	4.62e-05	0.000678	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NOTCH1—pancreatic cancer	4.6e-05	0.000675	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MET—pancreatic cancer	4.52e-05	0.000664	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—SRC—pancreatic cancer	4.52e-05	0.000663	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—SRC—pancreatic cancer	4.51e-05	0.000662	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMP—pancreatic cancer	4.49e-05	0.000658	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—HRAS—pancreatic cancer	4.46e-05	0.000654	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—pancreatic cancer	4.4e-05	0.000646	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—SRC—pancreatic cancer	4.4e-05	0.000645	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—pancreatic cancer	4.39e-05	0.000645	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—STAT3—pancreatic cancer	4.36e-05	0.00064	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NOTCH1—pancreatic cancer	4.35e-05	0.000639	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—NRAS—pancreatic cancer	4.35e-05	0.000638	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GLP1R—pancreatic cancer	4.35e-05	0.000638	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—NRAS—pancreatic cancer	4.34e-05	0.000637	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PPARG—pancreatic cancer	4.34e-05	0.000637	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—HRAS—pancreatic cancer	4.34e-05	0.000636	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—pancreatic cancer	4.28e-05	0.000628	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—DPYD—pancreatic cancer	4.28e-05	0.000627	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—STAT3—pancreatic cancer	4.24e-05	0.000622	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—NRAS—pancreatic cancer	4.23e-05	0.000621	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MMP9—pancreatic cancer	4.2e-05	0.000616	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GLP1R—pancreatic cancer	4.12e-05	0.000604	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PPARG—pancreatic cancer	4.11e-05	0.000603	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KDR—pancreatic cancer	4.06e-05	0.000596	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SLC2A2—pancreatic cancer	4.06e-05	0.000595	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—DPYD—pancreatic cancer	4.05e-05	0.000594	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TGFB1—pancreatic cancer	4.04e-05	0.000593	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	4e-05	0.000588	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TYMS—pancreatic cancer	3.99e-05	0.000585	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP2—pancreatic cancer	3.98e-05	0.000585	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—HRAS—pancreatic cancer	3.98e-05	0.000584	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MET—pancreatic cancer	3.97e-05	0.000583	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP9—pancreatic cancer	3.97e-05	0.000583	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—pancreatic cancer	3.96e-05	0.000581	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—pancreatic cancer	3.95e-05	0.00058	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TGFB1—pancreatic cancer	3.93e-05	0.000577	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—SRC—pancreatic cancer	3.87e-05	0.000568	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—pancreatic cancer	3.86e-05	0.000567	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—pancreatic cancer	3.85e-05	0.000565	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SLC2A2—pancreatic cancer	3.84e-05	0.000564	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NOTCH1—pancreatic cancer	3.83e-05	0.000561	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP2—pancreatic cancer	3.77e-05	0.000554	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—pancreatic cancer	3.77e-05	0.000554	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—pancreatic cancer	3.77e-05	0.000553	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—pancreatic cancer	3.74e-05	0.000549	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—pancreatic cancer	3.74e-05	0.000548	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—NRAS—pancreatic cancer	3.72e-05	0.000546	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—pancreatic cancer	3.67e-05	0.000539	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—SRC—pancreatic cancer	3.66e-05	0.000538	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—pancreatic cancer	3.64e-05	0.000534	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GLP1R—pancreatic cancer	3.62e-05	0.000531	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PPARG—pancreatic cancer	3.61e-05	0.00053	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—pancreatic cancer	3.57e-05	0.000524	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CTNNB1—pancreatic cancer	3.56e-05	0.000523	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—DPYD—pancreatic cancer	3.56e-05	0.000522	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—NRAS—pancreatic cancer	3.52e-05	0.000517	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—AKT1—pancreatic cancer	3.51e-05	0.000516	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—pancreatic cancer	3.49e-05	0.000513	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—pancreatic cancer	3.49e-05	0.000512	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NOTCH1—pancreatic cancer	3.46e-05	0.000507	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—pancreatic cancer	3.39e-05	0.000498	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC2A2—pancreatic cancer	3.38e-05	0.000495	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP2—pancreatic cancer	3.31e-05	0.000486	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PPARG—pancreatic cancer	3.26e-05	0.000479	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—APOE—pancreatic cancer	3.24e-05	0.000476	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—SRC—pancreatic cancer	3.22e-05	0.000473	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—SRC—pancreatic cancer	3.22e-05	0.000472	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—pancreatic cancer	3.21e-05	0.000471	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—pancreatic cancer	3.2e-05	0.00047	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—pancreatic cancer	3.18e-05	0.000467	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—pancreatic cancer	3.18e-05	0.000466	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CD44—pancreatic cancer	3.14e-05	0.000461	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—pancreatic cancer	3.14e-05	0.00046	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—pancreatic cancer	3.14e-05	0.00046	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—pancreatic cancer	3.11e-05	0.000456	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NRAS—pancreatic cancer	3.1e-05	0.000455	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—NRAS—pancreatic cancer	3.1e-05	0.000454	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—pancreatic cancer	3.09e-05	0.000454	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—pancreatic cancer	3.07e-05	0.00045	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CTNNB1—pancreatic cancer	3.05e-05	0.000448	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—pancreatic cancer	3.03e-05	0.000445	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GCG—pancreatic cancer	3.01e-05	0.000442	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—pancreatic cancer	2.99e-05	0.000439	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CD44—pancreatic cancer	2.98e-05	0.000437	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CG—pancreatic cancer	2.93e-05	0.00043	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CTNNB1—pancreatic cancer	2.89e-05	0.000424	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TGFB1—pancreatic cancer	2.88e-05	0.000422	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GCG—pancreatic cancer	2.85e-05	0.000419	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—pancreatic cancer	2.84e-05	0.000416	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—STK11—pancreatic cancer	2.83e-05	0.000416	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPARG—pancreatic cancer	2.83e-05	0.000415	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—pancreatic cancer	2.82e-05	0.000414	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—pancreatic cancer	2.82e-05	0.000414	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—pancreatic cancer	2.81e-05	0.000412	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—SRC—pancreatic cancer	2.76e-05	0.000405	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—pancreatic cancer	2.73e-05	0.000401	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—pancreatic cancer	2.72e-05	0.0004	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—pancreatic cancer	2.69e-05	0.000395	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—pancreatic cancer	2.69e-05	0.000394	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—STK11—pancreatic cancer	2.68e-05	0.000394	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—pancreatic cancer	2.67e-05	0.000391	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—pancreatic cancer	2.67e-05	0.000391	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—pancreatic cancer	2.66e-05	0.000391	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NRAS—pancreatic cancer	2.66e-05	0.00039	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PRSS1—pancreatic cancer	2.62e-05	0.000385	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CD44—pancreatic cancer	2.61e-05	0.000384	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—SRC—pancreatic cancer	2.61e-05	0.000384	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—pancreatic cancer	2.58e-05	0.000378	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CD—pancreatic cancer	2.57e-05	0.000378	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—pancreatic cancer	2.55e-05	0.000374	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CTNNB1—pancreatic cancer	2.54e-05	0.000373	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—pancreatic cancer	2.52e-05	0.00037	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NRAS—pancreatic cancer	2.51e-05	0.000369	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GCG—pancreatic cancer	2.51e-05	0.000368	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—pancreatic cancer	2.49e-05	0.000366	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TGFB1—pancreatic cancer	2.47e-05	0.000362	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TYMS—pancreatic cancer	2.44e-05	0.000358	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—pancreatic cancer	2.42e-05	0.000355	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—STK11—pancreatic cancer	2.36e-05	0.000346	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TGFB1—pancreatic cancer	2.34e-05	0.000343	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TYMS—pancreatic cancer	2.31e-05	0.000339	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—pancreatic cancer	2.3e-05	0.000338	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SRC—pancreatic cancer	2.3e-05	0.000337	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—pancreatic cancer	2.29e-05	0.000336	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—pancreatic cancer	2.29e-05	0.000335	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ARG2—pancreatic cancer	2.27e-05	0.000333	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—pancreatic cancer	2.27e-05	0.000333	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—pancreatic cancer	2.27e-05	0.000332	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CB—pancreatic cancer	2.24e-05	0.000329	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—pancreatic cancer	2.24e-05	0.000328	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—pancreatic cancer	2.22e-05	0.000326	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—pancreatic cancer	2.22e-05	0.000325	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NRAS—pancreatic cancer	2.21e-05	0.000324	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—pancreatic cancer	2.18e-05	0.00032	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—pancreatic cancer	2.16e-05	0.000318	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—pancreatic cancer	2.05e-05	0.000301	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMS—pancreatic cancer	2.03e-05	0.000298	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—pancreatic cancer	2.01e-05	0.000295	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—pancreatic cancer	2e-05	0.000294	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMP—pancreatic cancer	1.99e-05	0.000291	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—APOE—pancreatic cancer	1.98e-05	0.000291	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—pancreatic cancer	1.94e-05	0.000285	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—pancreatic cancer	1.94e-05	0.000284	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—pancreatic cancer	1.92e-05	0.000281	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—pancreatic cancer	1.9e-05	0.000279	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—APOE—pancreatic cancer	1.88e-05	0.000275	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—pancreatic cancer	1.86e-05	0.000273	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—pancreatic cancer	1.84e-05	0.00027	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CG—pancreatic cancer	1.79e-05	0.000262	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARG—pancreatic cancer	1.73e-05	0.000253	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—pancreatic cancer	1.72e-05	0.000252	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CG—pancreatic cancer	1.69e-05	0.000249	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—APOE—pancreatic cancer	1.65e-05	0.000242	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARG—pancreatic cancer	1.63e-05	0.00024	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—pancreatic cancer	1.62e-05	0.000238	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—pancreatic cancer	1.62e-05	0.000237	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GLP1R—pancreatic cancer	1.6e-05	0.000235	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—DPYD—pancreatic cancer	1.57e-05	0.000231	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CD—pancreatic cancer	1.57e-05	0.000231	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.49e-05	0.000219	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CD—pancreatic cancer	1.49e-05	0.000218	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CG—pancreatic cancer	1.49e-05	0.000218	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARG—pancreatic cancer	1.44e-05	0.000211	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—pancreatic cancer	1.43e-05	0.000209	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CB—pancreatic cancer	1.37e-05	0.000201	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—pancreatic cancer	1.37e-05	0.000201	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—pancreatic cancer	1.36e-05	0.000199	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CD—pancreatic cancer	1.31e-05	0.000192	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CB—pancreatic cancer	1.3e-05	0.00019	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—pancreatic cancer	1.29e-05	0.000189	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—pancreatic cancer	1.29e-05	0.000189	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.22e-05	0.000179	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—pancreatic cancer	1.18e-05	0.000174	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CD44—pancreatic cancer	1.16e-05	0.00017	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CB—pancreatic cancer	1.14e-05	0.000167	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—pancreatic cancer	1.13e-05	0.000166	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—pancreatic cancer	1.12e-05	0.000165	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—pancreatic cancer	1.12e-05	0.000164	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GCG—pancreatic cancer	1.11e-05	0.000163	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.06e-05	0.000155	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—STK11—pancreatic cancer	1.04e-05	0.000153	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—pancreatic cancer	9.85e-06	0.000145	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMP—pancreatic cancer	9.23e-06	0.000135	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMS—pancreatic cancer	8.97e-06	0.000132	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—pancreatic cancer	8.35e-06	0.000123	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—pancreatic cancer	7.91e-06	0.000116	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	7.44e-06	0.000109	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—DPYD—pancreatic cancer	7.32e-06	0.000107	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—APOE—pancreatic cancer	7.3e-06	0.000107	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—pancreatic cancer	6.95e-06	0.000102	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.95e-06	0.000102	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—pancreatic cancer	6.82e-06	0.0001	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	6.59e-06	9.67e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—pancreatic cancer	6.46e-06	9.48e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARG—pancreatic cancer	6.36e-06	9.33e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	5.79e-06	8.5e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—pancreatic cancer	5.68e-06	8.33e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CD44—pancreatic cancer	5.38e-06	7.9e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GCG—pancreatic cancer	5.16e-06	7.57e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	5.05e-06	7.41e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—pancreatic cancer	5e-06	7.34e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—STK11—pancreatic cancer	4.85e-06	7.12e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—pancreatic cancer	4.36e-06	6.4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMS—pancreatic cancer	4.17e-06	6.12e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—APOE—pancreatic cancer	3.39e-06	4.98e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	3.08e-06	4.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.06e-06	4.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.96e-06	4.34e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.69e-06	3.95e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—pancreatic cancer	2.51e-06	3.69e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.35e-06	3.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.32e-06	3.41e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.03e-06	2.98e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.43e-06	2.1e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.17e-06	1.71e-05	CbGpPWpGaD
